Comparison of Intraoperative and Postoperative Outcomes of Bartholin Gland Marsupialisation Versus Cystectomy

NCT ID: NCT03328429

Last Updated: 2018-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

154 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2018-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare intraoperative and postoperative outcomes of Bartholin marsupialisation versus excision

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bartholin cysts and abscess are commonly seen. Different surgical procedures are done for therapy. Our aim is to compare intraoperative results and postoperative healing of patients undergoing marsupialisation versus excision.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bartholin Abscess

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Marsupialization

Bartholin gland marsupialization will be done to all patients with Bartholin abscess.

Group Type OTHER

Marsupialization

Intervention Type OTHER

Bartholin gland will be marsupialised

Excision

Bartholin gland excision will be done to all patients with Bartholin abscess.

Group Type OTHER

Excision

Intervention Type OTHER

Bartholin gland will be excised

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Excision

Bartholin gland will be excised

Intervention Type OTHER

Marsupialization

Bartholin gland will be marsupialised

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-40, Bartholin cyst/abscess

Exclusion Criteria

* patients with systemical diseases, patients with recurrent Bartholin abscess
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Berna Aslan Cetin

Attending physician,ObGyn

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Berna Aslan Çein

Role: PRINCIPAL_INVESTIGATOR

KSSTRH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kanuni SSTRH

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Ozdegirmenci O, Kayikcioglu F, Haberal A. Prospective Randomized Study of Marsupialization versus Silver Nitrate Application in the Management of Bartholin Gland Cysts and Abscesses. J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):149-52. doi: 10.1016/j.jmig.2008.10.006.

Reference Type BACKGROUND
PMID: 19598336 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017/220

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.